Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: Analysis of 952 autologous peripheral blood stem cell transplantations

Bone Marrow Transplantation

Volumn 40, Issue 9, 2007, Pages 831-835

  Fois E ^a   Desmartin, M ^b   Benhamida, S ^b   Xavier, F ^a   Vanneaux, V ^a   Rea, D ^a   Fermand, J P ^a   Arnulf, B ^a   Mounier, N ^a   Ertault, M ^a   Lotz, J P ^c   Galicier, L ^a   Raffoux, E ^a   Benbunan, M ^a   Marolleau, J P ^d   Larghero, J ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b ECOLE CENTRALE PARIS   (France)

^c HÔPITAL TENON   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CELL COUNT; CELL LOSS; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; CYTOTOXICITY; FREEZE THAWING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MYELOMA; PRIORITY JOURNAL;

ANTIGENS, CD34; CELL COUNT; CELL SURVIVAL; CRYOPRESERVATION; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 35649017146     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705830     Document Type: Article

References (28)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. Mazur P. Cryobiology: The freezing of biological systems. Science 1970; 168: 939-949.
3. Rowley SD. Hematopoietic stem cell cryopreservation: A review of current techniques. J Hematother 1992; 1: 233-250.
4. Sputtek A, Körber C. Cryopreservation of red blood cells, platelets, lymphocytes, and stem cells. In: Fuller BJ, Grout BWW (eds). Clinical Applications of Cryobiology. CRC Press: Boca Raton, 1991, pp 95-147.
5. De Boer F, Dräger AM, Pinedo HM, Kessler FL, Van der Wall E, Jonkhoff AR et al. Extensive early apoptosis in frozenthawed CD 34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002; 29: 249-255.
6. Sartor M, Antonenas V, Garvin F, Webb M, Bradstock KF. Recovery of viable CD34 + cells from cryopreserved hemopoietic progenitor cell products. Bone Marrow Transplant 2005; 36: 199-204.
7. Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M et al. Number of viable CD34 + cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 967-972.
8. Mazur P. Theoretical and experimental effects of cooling and warming velocity on the survival of frozen and thawed cells. Cryobiology 1966; 2: 181-192.
9. Abrahamsen JF, Bakken AM, Bruserud O. Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34 + cells. Transfusion 2002; 42: 1573-1580.
10. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705-4708.
11. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: Analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533-537.
12. Sauer-Heilborn A, Kadidlo D, McCullough J. Patient care during infusion of hematopoietic progenitor cells. Transfusion 2004; 44: 907-916.
13. Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ. Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 1991; 7: 401-403.
14. Zenhausern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide cryopreserved hematopoietic stem cells in a patient with a severe primary cardiac amyloidosis and end stagerefial failure. Ann Hematol 2000; 79 523-526.
15. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000; 25: 1285-1287.
16. Dnodapkar M, Goldberg SL, Tefferi A, Gertz MA. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994; 45: 187-188.
17. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethyl sulfoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 2000; 25: 1299-1301.
18. Smith DM, Weisenburger DD, Bierman P, Kessinger A, Vaugnah WP, Armitage JO. Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 1987; 2: 195-201.
19. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521-526.
20. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781-786.
21. Spurr EE, Wiggins, NE, Marsden KA, Lowenthal RM, Ragg SJ. Cryopreserved human hematopoietic stem cells retain engrafment potential after extended (5-14 years) cryostorage. Cryobiology 2002; 44: 210-217.
22. Rowley SD. Techniques of bone marrow and stem cells cryopreservation and storage. In: Sacher RA, Aubuchon JP (eds). Marrow Transplantation: Practical and Technical Aspects of Stem Cells Reconstitution. American Association of Blood Banks: Bethesda, 1992, pp 105-127.
23. Rowley SD, Bensinger WI, Gooley TA, Buckner CD. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994; 83: 2731-2736.
24. Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM et al. Viability of cryopreserved BM progenitor cells stored for raore than a decade. Cytotherapy 2002; 4: 157-163.
25. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA 2003; 100: 645-650.
26. Keung YK, Lau S, Elkayam U, Chen SC, Douer D. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994; 14: 363-367.
27. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Glück S. The role of depletion of dimethyl sulfoxide before autografting: On hematologic recovery, side effects and toxicity. Biol Blood Marrow Transplant 2004; 10: 135-141.
28. Lemarie C, Calmels B, Malenfant C, Arneodo V, Blaise D, Viret F et al. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: Cytomate. Transfusion 2005; 45: 737-742.